The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
We expect the global cannula market to exhibit a CAGR of around 7% during 2021-2026.
Sudden outbreak of the COVID-19 pandemic had led to the increase in demand for cannula across the healthcare sector to treat severely infected patients from coronavirus.
The high prevalence of numerous chronic diseases, such as cardiac arrest, cancer, respiratory disorders, etc., along with the growing number of surgical procedures, are some of the factors catalyzing the global cannula market.
Based on the product, the global cannula market has been categorized into cardiac cannulas, vascular cannulas, nasal cannulas, dermatology cannulas, arthroscopy cannulas, and others. Among these, cardiac cannulas currently hold the majority of the share in the market.
Based on the type, the global cannula market has been segmented into neonatal cannulas, winged cannulas, straight cannulas, wing with port cannulas, and others, where straight cannulas account for the majority of the total market share.
Based on the size, the global cannula market has been bifurcated into 14G, 16G, 18G, 20G, 22G, 24G, and 26G. Currently, 18G sized cannula holds the majority of the total market share.
Based on the material, the global cannula market has been divided into plastic (PVC) cannulas, silicone cannulas, and metal cannulas (stainless steel). Among these, plastic (PVC) cannulas currently represent the largest segment.
Based on the end-user, the global cannula market has been segregated into hospitals, ambulatory surgery centers (ASCs), and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global cannula market include Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith+Nephew, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, Terumo Corporation, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at